
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Heart failure treatment becomes more affordable with Glenmark launching theSacubitril + Valsartan tablets in India".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Heart failure treatment becomes more affordable with Glenmark launching theSacubitril + Valsartan tablets in India".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals